Cargando…

Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells

[Image: see text] Pancreatic cancer cells overexpressing Mucin 1 (MUC1) rely on aerobic glycolysis and, correspondingly, are dependent on glucose for survival. Our NMR metabolomics comparative analysis of control (S2–013.Neo) and MUC1-overexpressing (S2–013.MUC1) cells demonstrates that MUC1 reprogr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gebregiworgis, Teklab, Purohit, Vinee, Shukla, Surendra K., Tadros, Saber, Chaika, Nina V., Abrego, Jaime, Mulder, Scott E., Gunda, Venugopal, Singh, Pankaj K., Powers, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2017
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634392/ https://www.ncbi.nlm.nih.gov/pubmed/28809118 http://dx.doi.org/10.1021/acs.jproteome.7b00246

Ejemplares similares

Correction: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
por: Shukla, Surendra K, et al.
Publicado: (2014)

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
por: Shukla, Surendra K, et al.
Publicado: (2014)

MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

MUC16-mediated activation of mTOR and c-MYC reprograms pancreatic cancer metabolism
por: Shukla, Surendra K., et al.
Publicado: (2015)

Metabolic Alterations in Pancreatic Cancer Progression
por: Vernucci, Enza, et al.
Publicado: (2019)

CD73 Induces GM-CSF/MDSC-mediated Suppression of T cells to Accelerate Pancreatic Cancer Pathogenesis
por: King, Ryan J., et al.
Publicado: (2022)

Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
por: Shukla, Surendra K., et al.
Publicado: (2015)

Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine–dependent interface: a model for KRAS oligomerization
por: Lee, Ki-Young, et al.
Publicado: (2021)

Differential Expression of Metabolic Genes in Tumor and Stromal Components of Primary and Metastatic Loci in Pancreatic Adenocarcinoma
por: Chaika, Nina V., et al.
Publicado: (2012)

Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3
por: Yang, Shuping, et al.
Publicado: (2015)

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
por: Creaney, J, et al.
Publicado: (2008)

The Synergistic Effect of an ATP-Competitive Inhibitor of mTOR and Metformin on Pancreatic Tumor Growth
por: Soliman, Ghada A, et al.
Publicado: (2020)

Structure and Function of Human DnaJ Homologue Subfamily A Member 1 (DNAJA1) and Its Relationship to Pancreatic Cancer
por: Stark, Jaime L., et al.
Publicado: (2014)

Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
por: Fang, Jun, et al.
Publicado: (2023)

Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response
por: Wang, Hao, et al.
Publicado: (2020)

Validation of Metabolic Alterations in Microscale Cell Culture Lysates Using Hydrophilic Interaction Liquid Chromatography (HILIC)-Tandem Mass Spectrometry-Based Metabolomics
por: Gunda, Venugopal, et al.
Publicado: (2016)

Overexpression of MUC1 predicts poor prognosis in patients with breast cancer
por: Jing, Xuan, et al.
Publicado: (2019)

Systems-based approaches to study immunometabolism
por: Purohit, Vinee, et al.
Publicado: (2022)

MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERα) in regulation of the MUC1 gene expression
por: Zaretsky, Joseph Z, et al.
Publicado: (2006)

Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection
por: Park, Kwang Kuk, et al.
Publicado: (2015)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Glutamine: A novel approach to chemotherapy-induced toxicity
por: Gaurav, Kumar, et al.
Publicado: (2012)

Metabolic Regulation of Redox Balance in Cancer
por: Purohit, Vinee, et al.
Publicado: (2019)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer
por: Xiao, Xiuying, et al.
Publicado: (2013)

Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice
por: Hancock, Laura A., et al.
Publicado: (2018)

Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression
por: Lin, Xiaozeng, et al.
Publicado: (2017)

Comparison of the Transmembrane Mucins MUC1 and MUC16 in Epithelial Barrier Function
por: Gipson, Ilene K., et al.
Publicado: (2014)

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components
Publicado: (1995)

MUC16 overexpression induced by gene mutations promotes lung cancer cell growth and invasion
por: Kanwal, Madiha, et al.
Publicado: (2018)

Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4
por: Gál, Eleonóra, et al.
Publicado: (2020)

Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
por: Bose, Mukulika, et al.
Publicado: (2022)

Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012)

Immunohistochemical detection of MUC5AC and MUC5B mucins in ferrets
por: Meyerholz, David K., et al.
Publicado: (2023)

Characterization of recombinant β subunit of human MUC4 mucin (rMUC4β)
por: Kshirsagar, Prakash G., et al.
Publicado: (2021)

Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas
por: Do, Sung-Im, et al.
Publicado: (2013)

Degradation of MUC7 and MUC5B in Human Saliva
por: Takehara, Sachiko, et al.
Publicado: (2013)

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)
por: Hanson, Ryan L., et al.
Publicado: (2016)

Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
por: Senapati, Shantibhusan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0r2jdt6gnirq4ccmjei3ibsp3l